Reda Ibrahem

558 total citations
31 papers, 377 citations indexed

About

Reda Ibrahem is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Reda Ibrahem has authored 31 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Reda Ibrahem's work include COVID-19 Clinical Research Studies (3 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Reda Ibrahem is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Reda Ibrahem collaborates with scholars based in Egypt, Saudi Arabia and United States. Reda Ibrahem's co-authors include Mohamed S. Omar, Reda Z. Mahfouz, Azza Gaber Antar Farag, Sahar M. Abdel Galil, Moustafa Sakr, Gaafar Abdel Rasoul, Amani E. Badawi, Nagwa Hegazy, Ashraf Anas Zytoon and Yasser M. El‐Sherbiny and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pediatric Research and Journal of Thoracic Oncology.

In The Last Decade

Reda Ibrahem

27 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reda Ibrahem Egypt 12 80 68 54 54 53 31 377
Andrea P. Malizia Italy 12 57 0.7× 124 1.8× 58 1.1× 45 0.8× 59 1.1× 24 500
Aaron Baraff United States 9 20 0.3× 35 0.5× 43 0.8× 60 1.1× 27 0.5× 18 270
Kathryn P Trayes United States 6 59 0.7× 91 1.3× 50 0.9× 20 0.4× 39 0.7× 11 458
Naseh Sigari Iran 12 36 0.5× 58 0.9× 77 1.4× 62 1.1× 47 0.9× 23 317
Tu My To United States 9 21 0.3× 26 0.4× 28 0.5× 23 0.4× 70 1.3× 41 361
Philippe Arvers France 12 26 0.3× 34 0.5× 29 0.5× 13 0.2× 59 1.1× 32 356
Fatemeh Tajik Iran 9 32 0.4× 55 0.8× 21 0.4× 17 0.3× 106 2.0× 33 307
Veronica Fitzpatrick United States 10 22 0.3× 34 0.5× 23 0.4× 35 0.6× 47 0.9× 28 323
Dimitrios Anyfantakis Greece 12 16 0.2× 33 0.5× 57 1.1× 30 0.6× 17 0.3× 53 534
Shunying Zhao China 16 39 0.5× 120 1.8× 79 1.5× 165 3.1× 26 0.5× 52 656

Countries citing papers authored by Reda Ibrahem

Since Specialization
Citations

This map shows the geographic impact of Reda Ibrahem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reda Ibrahem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reda Ibrahem more than expected).

Fields of papers citing papers by Reda Ibrahem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reda Ibrahem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reda Ibrahem. The network helps show where Reda Ibrahem may publish in the future.

Co-authorship network of co-authors of Reda Ibrahem

This figure shows the co-authorship network connecting the top 25 collaborators of Reda Ibrahem. A scholar is included among the top collaborators of Reda Ibrahem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reda Ibrahem. Reda Ibrahem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crichton, Siobhan, Christopher N. Parris, Reda Ibrahem, et al.. (2025). 93P MDX-124, a novel anti-ANXA1 antibody, has significant anti-cancer activity in preclinical models of osteosarcoma. ESMO Open. 10. 104406–104406.
2.
Faqihi, Abdullah A., et al.. (2024). NATURAL OILS AS AN ECO-FRIENDLY LUBRICANT FOR MACHINING OPERATIONS, A REVIEW. 21(1). 78–90. 1 indexed citations
3.
Ibrahem, Reda, et al.. (2023). Sexual Satisfaction; Prevalence, Cofactors and its Relation to Mental Health of Egyptian Married Women. The Egyptian Journal of Hospital Medicine. 90(1). 248–254. 1 indexed citations
4.
Ibrahem, Reda, et al.. (2022). Commitment to COVID-19 Protective Measures in Schools and among School Children, Egypt. The Egyptian Journal of Hospital Medicine. 89(1). 4332–4339.
5.
Ibrahem, Reda, et al.. (2022). Internet Addiction in Relation to Mental Health among Medical Students, Menoufia University, Egypt. The Egyptian Journal of Hospital Medicine. 88(1). 2325–2331. 5 indexed citations
6.
Ibrahem, Reda, et al.. (2021). The severity and atypical presentations of COVID-19 infection in pediatrics. BMC Pediatrics. 21(1). 144–144. 29 indexed citations
7.
Ibrahem, Reda, et al.. (2021). Surfactant protein D: a predictor for severity of community-acquired pneumonia in children. Pediatric Research. 91(3). 665–671. 7 indexed citations
8.
Ibrahem, Reda, et al.. (2021). Circulating miR-21-5p and miR-126-3p: diagnostic, prognostic value, and multivariate analysis in non-small-cell lung cancer. Molecular Biology Reports. 48(3). 2543–2552. 13 indexed citations
9.
El‐Sherbiny, Yasser M., et al.. (2021). SELECTION OF FLOOR MATERIALS IN HOSPITALS TO RESIST COVID-19. 18(1). 40–51. 5 indexed citations
10.
11.
Ibrahem, Reda, et al.. (2018). Prognostic Factors for Hormone Sensitive Metastatic Prostate Cancer: Impact of Disease Volume. PubMed. 19(4). 1113–1118. 7 indexed citations
12.
Ibrahem, Reda, et al.. (2018). Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer. Biochemistry and Biophysics Reports. 15. 45–51. 40 indexed citations
13.
Farag, Azza Gaber Antar, et al.. (2018). Epidemiology of dermatophyte infections among school children in Menoufia Governorate, Egypt. Mycoses. 61(5). 321–325. 20 indexed citations
14.
Farag, Azza Gaber Antar, et al.. (2018). Mean platelet volume. Journal of the Egyptian Womenʼs Dermatologic Society. 15(2). 80–87. 8 indexed citations
15.
Galil, Sahar M. Abdel, et al.. (2017). Serum miR-210 and miR-155 expression levels as novel biomarkers for rheumatoid arthritis diagnosis. British Journal of Biomedical Science. 74(4). 209–213. 43 indexed citations
16.
17.
18.
19.
Ibrahem, Reda, et al.. (2015). Internet Addiction and Psychological Morbidity among Menoufia University Students, Egypt. American journal of public health research. 3(5). 192–198. 20 indexed citations
20.
Rasoul, Gaafar Abdel, et al.. (2013). Prevalence of depression, anxiety, and obsessive–compulsive disorders among secondary school students in Menoufia Governorate, Egypt. Menoufia Medical Journal. 26(1). 44. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea P. Malizia Breakdown of academic impact, for papers by Aaron Baraff Breakdown of academic impact, for papers by Kathryn P Trayes Breakdown of academic impact, for papers by Naseh Sigari Breakdown of academic impact, for papers by Tu My To Breakdown of academic impact, for papers by Philippe Arvers Breakdown of academic impact, for papers by Fatemeh Tajik Breakdown of academic impact, for papers by Veronica Fitzpatrick Breakdown of academic impact, for papers by Dimitrios Anyfantakis Breakdown of academic impact, for papers by Shunying Zhao
Rankless by CCL
2026